SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-011156
Filing Date
2020-01-21
Accepted
2020-01-21 17:29:41
Documents
14
Period of Report
2020-01-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d872820d8k.htm   iXBRL 8-K 29474
2 EX-99.1 d872820dex991.htm EX-99.1 23993
6 GRAPHIC g872820im1.jpg GRAPHIC 2735
  Complete submission text file 0001193125-20-011156.txt   193252

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hznp-20200121.xsd EX-101.SCH 3085
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20200121_lab.xml EX-101.LAB 18840
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20200121_pre.xml EX-101.PRE 11849
16 EXTRACTED XBRL INSTANCE DOCUMENT d872820d8k_htm.xml XML 3602
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 20537135
SIC: 2834 Pharmaceutical Preparations